AU2020222120A1 - Method for treating pregancy-induced hypertension nephrosis - Google Patents

Method for treating pregancy-induced hypertension nephrosis Download PDF

Info

Publication number
AU2020222120A1
AU2020222120A1 AU2020222120A AU2020222120A AU2020222120A1 AU 2020222120 A1 AU2020222120 A1 AU 2020222120A1 AU 2020222120 A AU2020222120 A AU 2020222120A AU 2020222120 A AU2020222120 A AU 2020222120A AU 2020222120 A1 AU2020222120 A1 AU 2020222120A1
Authority
AU
Australia
Prior art keywords
antithrombin
administration
preeclampsia
mmhg
pregnancy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020222120A
Other languages
English (en)
Inventor
Yuichi Endo
Hironori Kanda
Masaya Kato
Kayoko Motoyama
Takashi Murayama
Yoshihide Nakamura
Shunichiro Orihara
Ryutaro Shimazaki
Kenichi Takagi
Tomoko Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Kirin Co Ltd filed Critical Kyowa Kirin Co Ltd
Publication of AU2020222120A1 publication Critical patent/AU2020222120A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2020222120A 2019-02-11 2020-02-10 Method for treating pregancy-induced hypertension nephrosis Abandoned AU2020222120A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962803888P 2019-02-11 2019-02-11
US62/803,888 2019-02-11
US201962820459P 2019-03-19 2019-03-19
US62/820,459 2019-03-19
PCT/JP2020/005130 WO2020166557A1 (ja) 2019-02-11 2020-02-10 妊娠高血圧腎症の治療方法

Publications (1)

Publication Number Publication Date
AU2020222120A1 true AU2020222120A1 (en) 2021-09-02

Family

ID=72044881

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020222120A Abandoned AU2020222120A1 (en) 2019-02-11 2020-02-10 Method for treating pregancy-induced hypertension nephrosis

Country Status (7)

Country Link
US (1) US20220202920A1 (https=)
EP (1) EP3925616A4 (https=)
JP (2) JPWO2020166557A1 (https=)
AU (1) AU2020222120A1 (https=)
CA (1) CA3129755A1 (https=)
TW (1) TW202045203A (https=)
WO (1) WO2020166557A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021112606A1 (ko) 2019-12-05 2021-06-10 주식회사 엘지에너지솔루션 리튬 이차전지용 양극 활물질, 상기 양극 활물질의 제조 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07316072A (ja) * 1994-05-24 1995-12-05 Green Cross Corp:The 妊娠中毒症治療剤
CN1890262B (zh) 2003-10-09 2015-01-28 协和发酵麒麟株式会社 抗凝血酶ⅲ组合物的制造方法
WO2008120801A1 (ja) 2007-04-02 2008-10-09 Kyowa Hakko Kirin Co., Ltd. アンチトロンビン組成物の製造方法
US20180104318A1 (en) * 2015-03-31 2018-04-19 Kyowa Hakko Kirin Co., Ltd. Therapeutic composition containing antithrombin gamma

Also Published As

Publication number Publication date
EP3925616A4 (en) 2022-12-21
TW202045203A (zh) 2020-12-16
JPWO2020166557A1 (ja) 2021-12-16
EP3925616A1 (en) 2021-12-22
JP2023060011A (ja) 2023-04-27
WO2020166557A1 (ja) 2020-08-20
CA3129755A1 (en) 2020-08-20
US20220202920A1 (en) 2022-06-30

Similar Documents

Publication Publication Date Title
Paidas et al. Prospective, randomized, double-blind, placebo-controlled evaluation of the pharmacokinetics, safety and efficacy of recombinant antithrombin versus placebo in preterm preeclampsia
Poon Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus
NO20140969L (no) Anvendelse av digoksin immunt Fab for regulering av natrium/kalium-ATPase-aktivitet hos preklampsiske og eklampsiske pasienter
US20220202920A1 (en) Method for treating preeclampsia
Tolcher et al. Complications of Preeclampsia
CA2492858C (en) Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients
Van Ypersele de Strihou Should anaemia in subtypes of CRF patients be managed differently?
Tamás et al. Calcium dobesilate lowers the blood pressure in mild to moderate midtrimester hypertension: a pilot study
Ray et al. Assessment of iron status in patient of sickle cell disease and trait and its relationship with the frequency of blood transfusion in paediatric patients attending at BS Medical College & Hospital, Bankura, West Bengal, India
US20200147188A1 (en) Therapeutic composition containing antithrombin gamma
DK2961422T3 (en) Therapeutic agent for amniotic fluid embolism
Shayanpour et al. Evaluating intradialytic change of serum magnesium and its relation to intradialytic complications in chronic hemodialysis patients during one-month period
RU2438191C1 (ru) Способ коррекции гипоэстроген-индуцированной эндотелиальной дисфункции смесью растворов гомеопатических разведений поликлональных кроличьих антител к эндотелиальной синтазе оксида азота человека - с12, с30, с200
RU2721291C1 (ru) Способ коррекции тромбообразования никорандилом при ADMA-подобной модели преэклампсии
KR20070014114A (ko) 괴사성 장염의 치료
Ibsen et al. Decision points in the management of pediatric septic shock
FRAKES Oxygen-Carrying Capacity and Delivery
Wang et al. Effect of hypertonic sodium chloride hydroxyethyl starch 40 on ET, TXB2, 6-keto-PGF1α, and ANP of preeclampsia in caesarean section
Shilpashree Comparison of Maternal Serum Calcium and Magnesium Levels in Preeclampsia and Normal Pregnant Woman
Atkinson Probing Cardiac Metabolism in Uraemic Cardiomyopathy
Dollins Part 2: Circulation
Fleck et al. 87 Sildenafil Influence on Cerebral Oxygenation Measured by Near-Infrared Spectroscopy in Infants After Cardiac Surgery
JP2014162789A (ja) 羊水塞栓症治療剤
Deurloo et al. 46: Maternal serum PP13 and ADAM12S as first trimester predictors of adverse pregnancy outcome
Jeyabalan et al. in pregnancy

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application